TERIFLUNOMIDE | N202992 | SANOFI AVENTIS US LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Sanofi-Aventis U.S. LLC et al v. Mylan Pharmaceuticals Inc. et al 3 patentsANDA 209702teriflunomide | D. Del. | 2017-01-10 | Terminated 2018-01-02 | — |
| D. Del. | 2017-01-03 | Terminated 2017-06-23 | — | |
Sanofi-Aventis U.S. LLC et al v. IMPAX Laboratories, Inc. 2 patentsANDA 209677teriflunomide | D. Del. | 2017-01-03 | Terminated 2017-04-21 | — |
Sanofi-Aventis U.S. LLC et al v. Cadila Healthcare Limited et al 2 patentsANDA 209549teriflunomide | D. Del. | 2016-12-22 | Terminated 2018-01-02 | — |
Sanofi-Aventis U.S. LLC et al v. Alvogen Pine Brook LLC 2 patentsANDA 209555teriflunomide | D. Del. | 2016-12-22 | Terminated 2018-01-02 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).